Aurinia Pharmaceuticals Inc · NASDAQ:AUPH
Aurinia Pharmaceuticals Inc shareholders
As of Sep 30, 2026, 268 institutions reported holding Aurinia Pharmaceuticals Inc, 59.2% of its shares. Largest: Tang Capital Management LLC, BlackRock and Goldman Sachs. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Aurinia Pharmaceuticals Inc | Change | Filed |
|---|---|---|---|---|
| Tang Capital Management LLC | 13M | 9.7% | no change | Nov 16, 2026 |
| BlackRock | 8.59M | 6.4% | +392K | Nov 13, 2026 |
| Goldman Sachs | 6.34M | 4.7% | +719K | Nov 16, 2026 |
| NEA Management Company, LLC | 3.97M | 3.0% | no change | Nov 16, 2026 |
| Arrowstreet Capital, Limited Partnership | 2.98M | 2.2% | −279K | Nov 13, 2026 |
| Two Sigma | 2.96M | 2.2% | −503K | Nov 16, 2026 |
| State Street | 2.59M | 1.9% | +2,715 | Nov 12, 2026 |
| Marshall Wace, LLP | 1.9M | 1.4% | −146K | Nov 13, 2026 |
| Lsv Asset Management | 1.81M | 1.3% | +728K | Nov 6, 2026 |
| Morgan Stanley | 1.79M | 1.3% | −516K | Nov 13, 2026 |